ISRCTN15065741已完成不适用
Phase II/III immunogenicity and safety clinical trial of a Meningococcus B Brazilian vaccine
Bio-Manguinhos/Fiocruz (Brazil)0 个研究点目标入组 240 人开始时间: 2009年3月27日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Both sexes
- •2. Aged between 4 years and 12 years
- •3. Agreement with Free and Informed Consent Form
- •4. Healthy children
排除标准
- •1. Personal history of meningitis or meningococcus B vaccine
- •2. Immunosupression
- •3. Use of blood products in the last 12 months
- •4. Use of penicillin in the last 30 days
- •5. Personal history of serious adverse event to any vaccination
研究者
相似试验
已完成
2 期
A Phase 2 study to assess the safety, immunogenicity and recommended dose of DS-5670a in Japanese healthy adultsJPRN-jRCT2071210086Inoguchi Akihiro80
招募中
2 期
Phase II Clinical Trial of Safety, Immunogenicity, and Mucosal Immunotherapy of Recombinant Lactococcus lactis Expressing Human Papillomavirus Type 16 E6/E7 Oncoprotein Vaccine in Women having Cervical Intraepithelial Neoplasia (CIN)Genital Wart.Anogenital (venereal) wartsA63.0IRCT20190504043464N2Iran University of Medical Sciences220
已完成
1 期
A Phase 1/2 study to assess the safety, immunogenicity and recommended dose of DS-5670a in Japanese healthy adults and elderly subjectsPrevention of COVID-19JPRN-jRCT2071200110Inoguchi Akihiro152
已完成
3 期
A clinical study to evaluate safety and compare immune responses of two formulations of a combined 5-in-1 DTwP-HepB-Hib vaccine in childreCTRI/2018/12/016692Shantha Biotechnics Pvt Ltd460
未知
2 期
DNK-ADUFLU-3JPRN-jRCT2080222415DENKA SEIKEN CO.,LTD.50